Who is sponsoring NCT00536068?

NCT00536068 is sponsored by Kantonsspital Graubünden.

What drugs are being tested in NCT00536068?

Interventions in NCT00536068: Acetylsalicylic acid, acetaminophen, diclofenac, naproxen, placebo.

What condition does NCT00536068 study?

NCT00536068 studies Hemostasis.

Is NCT00536068 still recruiting?

NCT00536068 is currently completed. Last updated 27 September 2007.

Last reviewed 2007-09-27 · How we verify

NCT00536068

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Platelet Inhibition by Aspirin, Acetaminophen and NSAID

Completed NA Last updated 27 September 2007

What this trial tests

NA trial testing Acetylsalicylic acid, acetaminophen, diclofenac, naproxen, placebo in Hemostasis in 11 participants. Completed in 1 August 2007.

Timeline

1 August 2006

1 August 2007

Quick facts

Lead sponsor	Kantonsspital Graubünden
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	single
Primary purpose	treatment
Enrollment	11
Start date	1 August 2006
Estimated completion	1 August 2007
Sites	1 location across Switzerland

Drugs / interventions tested

Acetylsalicylic acid, acetaminophen, diclofenac, naproxen, placebo — full drug profile →

Conditions studied

Hemostasis — all drugs for Hemostasis →

Sponsor

Kantonsspital Graubünden — full company profile →

Who can join

Eligibility, any sex, with Hemostasis. Healthy volunteers can join.

What's being measured

Primary outcomes are the specific endpoints the trial is designed to prove or disprove.

platelet aggregation
Time frame: 5 days

Sponsor's own description

Nonsteroidal antiinflammatory drugs such as diclofenac or naproxen may interfere with the inhibition of platelet aggregation by aspirin, because they all interact with the platelet cyclooxygenase.This may be of great clinical importance because of an increased cardiovascular event rate (myocardial infarction, stroke). The present randomized, controlled study analyses in vitro platelet aggregation under a combined treatment of healthy volunteers with aspirin and either acetaminophen, diclofenac, naproxen, or placebo.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Hemostasis

Currently open trials in the same condition.

NCT06664788 — A Study of ETHIZIA Versus SURGICEL Original in Controlling Soft Tissue Bleeding During Open Surgery · NA · recruiting
NCT03430609 — Ovarian Function After Use of Various Hemostatic Techniques During Treatment for Endometrioma · NA · active not recruiting

Other Kantonsspital Graubünden trials

Trials by the same sponsor.

NCT03808155 — Prevention of Postoperative Urinary Retention With Treatment of Tamsulosin 5 Days Prior to Lower Limb Arthroplasty · Phase 4 · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT00536068 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Kantonsspital Graubünden
Last refreshed: 27 September 2007

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT00536068.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing